Email Updates

You are here

Home

17 MAY 2019 VOLUME 20 ISSUE 19

Media Coverage

  • Will a Vaccine Crisis of Confidence Impact the Global Response to HIV?

    The implications of the anti-vaccination movement are enormous. Just as vaccines against some of the greatest global killers finally come within reach, fear and misinformation could diminish vital commitments to continued vaccine research, and important investments in vaccine education and delivery. Effective vaccines might not get developed, manufactured, distributed or used due to misguided, anti-vaccine sentiment — potentially putting millions of people at risk for entirely preventable deaths and diseases.

    May 17, 2019
    HIV Vaccine
    Science Speaks

  • Gilead CEO Insists Federal Government Patent for HIV Prevention Pill Truvada Is Invalid

    The chief executive of Gilead Sciences, the nation’s leading manufacturer of HIV drugs, defended the high cost of a key drug that prevents the lethal infection, telling a House committee Thursday that its hefty profits pay for continued research.

    May 16, 2019
    PrEP
    Washington Post

  • How Family Planning Clinics Can Influence Women to Take PrEP

    Pre-exposure prophylaxis (PrEP) for HIV prevention has become more well-known and has perhaps sparked more interest among men who have sex with men (MSM), meaning the percentage of at-risk women taking PrEP is unfortunately lagging. This is not only because women are unaware of PrEP; many providers lack knowledge of PrEP as well.

    May 16, 2019
    PrEP
    Contagion Live

  • Reaching Key Populations With HIV Services in India – Perfecting the Integrated Model

    Integrated services for key affected populations in India increased the number of people testing for HIV in the past 12 months by 31%, but the services did not reach enough people within the target groups to have a significant population-level effect.

    May 15, 2019
    General
    Avert

  • New HIV Map Offers Most Detailed Look Yet At The Epidemic

    A first-of-its-kind new map may help increase the precision of the HIV/AIDS response, as some data-savvy researchers narrow their focus on the continent's worst-affected areas — to the size of a small town.

    May 15, 2019
    General
    NPR

  • How High-Tech Computers Designed a Promising HIV Vaccine

    If only Darwin could see the high-tech version of his vision of evolution currently at work in the field of HIV vaccine research. Seeking to outfox a virus that evolves and mutates at a furious pace, researchers as Los Alamos National Laboratory (LANL) in Sante Fe, New Mexico, looked to a cutting-edge machine-learning algorithm to recapitulate HIV’s evolutionary patterns in an effort to develop a promising vaccine candidate.

    May 15, 2019
    HIV Vaccine
    POZ

  • Clinic Distance Impedes PrEP Programme Success in Uganda

    Geography and transportation barriers are associated with poor uptake of pre-exposure prophylaxis (PrEP) and care retention, reveals a new study from rural Uganda. Among those eligible to start PrEP, uptake was very low at 39% and of those who started PrEP just 17% attended the initial four-week follow-up.

    May 14, 2019
    PrEP
    Avert

  • Rate of Undiagnosed HIV Remains High Among Black African Heterosexuals in London

    The rate of undiagnosed HIV infection among heterosexual black Africans living in London remains unacceptably high, according to research published in JAMA Network Open. Oral testing showed that over 50% of men and 40% of women who reported they were HIV negative/untested were in fact HIV positive. There were also high levels of HIV risk behaviour, with a fifth of women and quarter of men reporting condomless last sex with a partner of different or unknown HIV status in the past year.

    May 14, 2019
    General
    aidsmap

  • Making Trans Women Count in HIV Vaccine Trials

    Black transgender women have very high rates of HIV in the United States, but due to discrimination, poverty, and violence, they face many challenges receiving health care services. As more resources for HIV vaccine and cure research have been promised through the newly announced federal "Ending the HIV Epidemic" plan, increasing participation of transgender individuals in vaccine research will be a high priority.

    May 14, 2019
    The BodyPro

  • A Million Americans Need This Drug. Trump’s Deal Won’t Help Enough of Them

    At first blush, the news that Gilead — the company that makes Truvada, the medication that prevents HIV infection — will donate enough of the drug to treat 200,000 patients a year through 2030 seems like unequivocally good news. Some 40,000 Americans are newly infected with H.I.V. every year. Reducing that transmission rate is the key to eradicating the virus in the United States, as President Trump has vowed to do by 2030. And increasing access to Truvada is widely seen as the best way to do that.

    May 13, 2019
    PrEP
    New York Times

  • The Big Number: 1.1 Million People in the US Live With HIV

    In the United States, about 1.1 million people age 13 and older are living with HIV, the virus that causes AIDS, according to the Centers for Disease Control and Prevention. A decade ago, the number of U.S. infections was declining substantially each year, but that stopped in 2013. Since then, about 39,000 people have become newly infected every year, which prompted the CDC this year to declare the nation’s progress in preventing HIV has stalled.

    May 13, 2019
    General
    Washington Post

  • Despite Uptick, Black and Latinx People Have Relatively Low Participation in HIV Vaccine Trials

    Black and Latinx people historically have not willfully participated in clinical trials in high numbers. Medical mistrust of research and health care institutions has long been a problem for conducting biomedical research. So what's causing the racial disparities in research participation, and what are researchers doing about it?

    May 13, 2019
    General
    The BodyPro

  • Officials Probe Alarming HIV Outbreak in Southern Pakistan

    Officials in Pakistan and the United Nations are investigating causes of a new outbreak of HIV infections in a southern district where nearly 400 people have been diagnosed in less than two weeks. Officials confirmed Saturday that nearly 80 percent of those infected are children, with nearly half of them under age 5.

    May 11, 2019
    General
    VOA

  • New Campaign, Toolkit Gets Providers PrEP'd for Women

    It's true that the way PrEP was initially introduced to most communities, it seemed as though PrEP was only for gay men or people with a lot of sex partners -- so it's no wonder PrEP prescriptions for women have been low. But New York City is trying to change that. On May 9, 2019, the New York City Department of Health and Mental Hygiene (NYC DOHMH) launched a new campaign targeted at educating women's health providers, including family planning, OB/GYN, and primary care providers, about the medications HIV-negative women can take to stay HIV negative.

    May 10, 2019
    PrEP
    The BodyPro

  • Kenya Pledges New Investments to Boost War Against HIV/AIDS

    Kenya will channel additional resources towards community-led interventions aimed at boosting prevention and treatment of HIV and AIDS that affects an estimated 5.6 percent of the country's population, officials said on Thursday.

    May 10, 2019
    General
    Xinhua

  • Better, Safer Sex: On the Hunt for a Condom People Will Actually Like

    When biomedical engineer Robert Gorkin saw the Bill and Melinda Gates Foundation’s 2013 call for submissions for a next-generation condom, he was hardly a contraceptive innovator. Rather, his work focused on 3D-printing organs and prosthetics. But when he reviewed the initiative’s goals — funding would be awarded to applicants who proposed a pleasurable, easy-to-use condom, thus encouraging regular use worldwide — Gorkin, a research fellow at Australia’s University of Wollongong, saw an opportunity.

    April 25, 2019
    Male and Female Condoms, Multipurpose Prevention Technologies
    Rolling Stone

Published Research

Announcements